Keryx Biopharmaceuticals Product Pipeline Review 2012


Naperville, IL -- (SBWIRE) -- 07/02/2012 -- Keryx Biopharmaceuticals Product Pipeline Review 2012 provides data on the Keryx Biopharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.


- Keryx Biopharmaceuticals, Inc. - Brief Keryx Biopharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Keryx Biopharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Keryx Biopharmaceuticals, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Keryx Biopharmaceuticals, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Keryx Biopharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Keryx Biopharmaceuticals, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Keryx Biopharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Keryx Biopharmaceuticals, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Keryx Biopharmaceuticals, Inc. and identify potential opportunities in those areas.


Current R&D Portfolio of Keryx Biopharmaceuticals, Inc.; Keryx Biopharmaceuticals, Inc. - Key Therapeutics; Keryx Biopharmaceuticals, Inc. - Pipeline Overview and Promising Molecules; Keryx Biopharmaceuticals, Inc. - News; Keryx Biopharmaceuticals, Inc. - Latest Updates; Keryx Biopharmaceuticals, Inc. - Pipeline; Keryx Biopharmaceuticals, Inc. - Discontinued/Dormant Projects

To view the detailed table of contents for this report please visit: